Zdrowie i gospodarka · 10/12/2021
FDA Classifies Transcutaneous Electrical Nerve Stimulator for ADHD into Class II with Special Controls
The FDA has classified the transcutaneous electrical nerve stimulator for attention deficit hyperactivity disorder (ADHD) into Class II with special controls, aiming to ensure the device's safety and effectiveness while enhancing patient access to innovative treatments.
Source: Federal Register — Food and Drug AdministrationOpen original release →